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Introduction
Postoperative venous thromboembolism (VTE) is a common
source of morbidity and mortality in general surgical patients,
and the incidence of this condition is well documented in the
Western medical literature. The relatively high incidence of
this disease and the dire consequences of the associated com-
plications are the rationale for prophylaxis in the West, even
though wide variation in the practice of VTE prophylaxis
continues to be reported.1
There is a paucity of evidence on the actual incidence of
this preventable cause of death in Malaysia and, indeed, in
many Asian countries. Contemporary studies, however, indi-
cate that the incidence of deep vein thrombosis (DVT) is
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increasing in the Asian population and the use of VTE prophy-
laxis in Asian patients should be no different from that in
Western patients,2–4 with minimal objective evidence to sug-
gest otherwise.
Although there are various simple and effective means of
VTE prophylaxis available today, most surgeons are reluctant
to use prophylaxis on a routine basis. This is probably due to
lack of published data on the actual incidence of DVT and
pulmonary embolism (PE) in postoperative patients in this
country. Furthermore, the clinically silent nature of this dis-
ease is often misleading, giving the impression that the inci-
dence of VTE is much lower than it actually is.
Surveys conducted in Western countries where DVT inci-
dences are known to be higher have revealed a considerable
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variation, ranging between 28% and 100%,5–9 in the use of
prophylaxis among general surgeons. This survey was con-
ducted to assess the current perception and attitude of general
surgeons in Malaysia to the need for VTE prophylaxis in their
practice.
Methods
Questionnaires were distributed to 110 general surgeons at-
tending the annual Malaysian College of Surgeons meeting in
June 2002. Surgeons working within general, selected private
and university hospitals were included in the survey. Only
surgeons of specialist grade (senior registrars and consultants)
were included in the study. A structured proforma was used to
obtain information on the surgeons’ perception of the need
for routine VTE prophylaxis in their practice. The question-
naire sought the following information: whether the inci-
dence of VTE in Asians was similar to that in Western popu-
lations; the type of prophylaxis that was used; the indica-
tions and types of surgery where prophylaxis was given; dura-
tion of prophylaxis; and, lastly, VTE complications encoun-
tered over the last year (Table 1). All replies were anonymous.
Results
The response rate was 70%. Surgeons employed in govern-
ment hospitals (52%) accounted for the majority of returned
questionnaires. The rest were surgeons from university (32%)
and private hospitals (16%). Sixty percent of surgeons were of
the opinion that the incidence of VTE in Malaysia was not as
high as that in Western populations.
There was a high utilization of selective prophylaxis (99%),
with only one respondent using prophylaxis sporadically. The
three most important indications for using prophylaxis, in
Table 1. Questionnaire – venous thromboembolic prophylaxis in surgical patients
1. Grade of surgeon/specialist < 5 years/5–10 years/> 10 years
2. Institution Private practice/Government hospital/University
3. Do you think the incidence of VTE disease in Yes/No
   Malaysia is as common as in the West?
4. Current use of VTE prophylaxis Routine/Sporadic/Selectively/Not used
5. If used selectively, indicators for usage (from most Risk grading/Previous VTE disease/Malignancy/Obesity/Age/
   important to least likely)    Prolonged surgery
6. If prophylaxis is not used, please give reasons I don’t believe that VTE prophylaxis is indicated because of its
   low incidence/Risk of bleeding/Other side effects of heparin or
   LMWH/Cost of LMWH/Others, please state: ………….....………..
7. Surgical procedures for which VTE prophylaxis Colorectal surgery/Laparoscopic surgery/Upper GI surgery/Hepato-
    utilized [Answer may be more than one]    biliary surgery/Vascular surgery/All surgical procedures/Others
8. Type of prophylaxis employed UFH or LMWH/TED stocking + LMWH or UFH/Intermittent
   pneumatic compression/Warfarin
9. Presence of protocol/guidelines on VTE prophylaxis Yes/No
   in your department/hospital
10. Duration of VTE disease prophylaxis for major Single dose/24 hours/2–3 days/4–7 days/Until mobilization/
   surgery    Until discharge
11. Morbidity due to VTE in the past 1 year Yes/No
12. Mortality due to VTE in the past 1 year Yes/No
• If yes, please state surgical procedure involved ……………………………………………………........................……………
• Was patient on VTE prophylaxis? Yes/No
• Duration to the onset of morbidity/mortality after < 3 days/3–5 days/5–7 days/> 7 days/No answer/Intraoperative
     surgery
VTE = venous thromboembolism; LMWH = low molecular weight heparin; GI = gastrointestinal; UFH = unfractionated heparin; TED =
thromboembolic disease.
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order of frequency, were: a history of VTE (40%); risk assess-
ment grading (26%), which was essentially divided into low,
moderate, high and very high risk;1 and prolonged surgery,
which was defined as surgery lasting more than 2 hours (22%).
Those who did not use prophylaxis mostly cited the risk of
bleeding (42%) as the reason, followed by the cost of low
molecular weight heparins (LMWHs) (12%).
Respondents were allowed more than one answer to the
question of the procedures for which they used thrombo-
prophylaxis. Colorectal surgery (n = 62) was the most common
procedure, followed by vascular and upper gastrointestinal
surgery (Figure 1). The most common type of prophylaxis
employed was low-dose heparins (78%), of which LMWHs
(73%) were more popular than unfractionated heparin (UFH)
(Table 2). Thromboembolic disease (TED) stockings in com-
bination with low-dose heparin (18.2%) was the next most
common type of prophylaxis. Only one surgeon (1.3%) em-
ployed an intermittent pneumatic compression device, while
two (2.6%) used low-dose warfarin.
A total of 78% of clinicians used prophylaxis until mobili-
zation after major surgery (Figure 2), and 43% of the surgeons
surveyed were aware of an existing protocol on VTE disease
prophylaxis within their place of practice.
Figure 1. Type of surgery requiring prophylaxis. GI = gastrointestinal.
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Table 2. Most frequently used methods of prophylaxis
Type of prophylaxis n (%)
Heparin (UFH or LMWH) 60 (78)
TED stockings + UFH or LMWH 14 (18)
Intermittent pneumatic compression device  11 (1.3)
Warfarin  12 (2.6)
UFH = unfractionated heparin; LMWH = low molecular weight
heparin; TED = thromboembolic disease.
Table 3. Onset of postoperative venous thromboembolism-
related morbidity and mortality
Postoperative morbidity and mortality n (%)
< 3 days 18 (18)
3–5 days 19 (20)
5–7 days 17 (16)
> 7 days 11 (25)
No answer 18 (18)
Intraoperative 1 (2)
Figure 2. Duration of prophylaxis given.
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VTE-related morbidities were reported by 57% of surgeons
over the previous year, of which 39% were fatal. This was
mainly seen in elderly patients who underwent surgery for
colorectal cancers, followed by abdominal and pelvic malig-
nancies. Of the patients reported to have developed VTE
complications, 63% had not been given prophylaxis. Overall,
25% of patients developed VTE-related morbidity and mortal-
ity more than 1 week following surgery, while 18% suffered
similar complications within the first 3 days postoperatively
(Table 3).
Further analyses performed between surgeons who were
under the impression that the incidence of VTE was low
among Asians and those who thought the incidence was
comparable to that in the West revealed selective utilization of
VTE prophylaxis among both groups (98% vs 100%). There
were no other significant differences between the two
subgroups, but it was interesting to note that the former
group consisted mainly of surgeons with more than 10 years’
specialist experience (46%), who also had a predilection for
using UFH (72%). The latter group consisted mainly of sur-
geons with less than 5 years’ specialist experience (70%) and
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who favoured LMWH (40%) or a combination of TED stock-
ings with LMWH (40%) for VTE prophylaxis.
Discussion
VTE is an important cause of death in hospitalized patients,
especially in those who have undergone major surgical
procedures.1,10 While routine prophylaxis is increasingly be-
ing used in Western practice based on accepted protocols,
clinicians in the East have adopted routine prophylaxis at a
lower rate based on the belief that VTE is uncommon among
their patients. There are obvious limitations in this belief, as
support from autopsy-proven PE rates is lacking in the medi-
cal literature from Eastern countries due to the lower rate of
autopsies performed.11
Both DVT and PE manifest very few specific symptoms and
clinical diagnosis is often inadequate and unreliable, with the
onset of PE frequently being too rapid for any intervention to
be effective.1,10 Effective prophylaxis reduces the incidence of
DVT and PE significantly.2,10,12 Undetected DVT gives rise to
long-term morbidity, which not only leads to increased health
care costs but also increases the risk of recurrent VTE and its
associated morbidities.1
Despite evidence that VTE is on an increasing trend in
Asia,2–4,13 most surgeons seem reluctant to use thrombopro-
phylaxis routinely in their practice. An earlier study performed
in Malaysia reported a 12% incidence of DVT following surgery,
which is much lower than the Western incidence.14 Recent
studies among Asian patients have demonstrated DVT rates as
high as 63% after proximal hip and knee surgery and between
3% and 15% after general and colorectal surgery.2,3,15–17 There
are reports of a relatively high incidence of asymptomatic
DVT following surgery for colorectal malignancies in Asia.18
Similarly, a study from Singapore has recently reported an
almost twofold increase in the incidence of DVT among hos-
pitalized patients, from 7.9 to 15.8 per 10,000 hospital
admissions, over a period of 5 years (1992 to 1997).3
A random survey conducted at the Annual Malaysian
Ministry of Health Scientific Meeting in 1999 revealed that
only about 6% of clinicians used prophylaxis in their practice.
Based on the general lack of awareness of the need for
thromboprophylaxis and the increasing trends of DVT
reported, the committee published national clinical guide-
lines on VTE prophylaxis,19 which is an adaptation of those
from Scotland.20
The response rate of 70% in our survey can be considered
satisfactory and allows conclusions to be drawn about the use
of prophylaxis among general surgeons in this country. The
results indicate a significant increase in the use of prophylaxis,
with 99% of surgeons using prophylaxis selectively, which is
comparable to surveys from Western countries.6–8 However,
only 58% were aware of the existence of a protocol or guidelines
on VTE prophylaxis in their workplace.
The high rate of morbidity reported in this survey probably
suggests that the intensity of prophylaxis used was not matched
to the level of risk. Effective prophylaxis should be based on
risk assessment models,1,10 which are widely available and
regularly updated, to ensure that patients receive optimum
prophylaxis. Risk factors are cumulative and multiple risk
factors may occur in the same patient, thus increasing the risk
of developing VTE complications. Multivariate analysis has
been used to grade patients based on overall risk factors, even
though this is not always feasible in clinical practice and,
hence, not applicable for all patients.1
The commonest indication for prophylaxis in this survey
was a history of VTE, and this is in keeping with a threefold
increased incidence of developing DVT or PE following ab-
dominal surgery in such patients.10 The risk of developing
DVT following major abdominal surgery for malignancies
is about 30–35%, and this risk increases in the presence of
other risk factors such as increasing age and prolonged sur-
gery.4,10,18 Surprisingly, only 42% of surgeons in this survey felt
that age was an important risk factor, considering that pa-
tients over the age of 40 years with other risk factors are at
higher risk of VTE complications. Epidemiological studies
have reported that the elderly are most susceptible to PE, with
an incidence of 1.6% following major surgery.1 With better
health care, there will be an increase in the elderly patient
population and this is likely to lead to an increase in VTE-
related morbidity in the population.21
Surgeons who did not use prophylaxis cited the risk of
bleeding as their main fear. This complication can be over-
come by timing the dose of prophylaxis appropriately prior to
surgery or by using mechanical methods of prophylaxis.22,23
Furthermore, numerous clinical trials have demonstrated that
LMWH has an advantage over UFH as it is associated with less
risk of the increased intraoperative bleeding and wound hae-
matomas that have been reported with UFH.8,22–26 Indeed, the
most popular type of prophylaxis used in our survey was
pharmacological, with LMWH being the most frequently used.
The use of TED stockings in combination with LMWH was the
next most popular choice of prophylaxis. This simple method
is only effective when it offers adequate compression. There is
insufficient evidence to allow firm conclusions to be drawn on
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its effectiveness when used alone compared with combination
treatment with pharmacological methods.1,10,27
Most surgeons in our survey (78%) routinely administered
VTE prophylaxis until patients were fully mobile. The practice
of prolonged prophylaxis may increase in the future as studies
have consistently shown that DVT can occur anywhere up to
4 weeks after surgery.24,26 A recent randomized controlled trial
has even given support to the administration of LMWH for
prophylaxis for 4 weeks after surgery for abdominal or pelvic
cancer, with a significant demonstrable reduction in the inci-
dence of DVT.28
Another important reason that is frequently implicated in
the reluctance of surgeons to use prophylaxis in this region is
in relation to the perception that the incidence of VTE in the
individual’s practice is too low to warrant routine prophy-
laxis.1 This misconception is compounded by the clinically
silent nature of the disease. Lack of prospective audit or data,
which is commonplace in many surgical practices in this
region, and lack of stringent patient follow-up are additional
factors negating this false observation. Furthermore, autop-
sies are not regularly performed in this region, which makes it
difficult to estimate the actual incidence of fatal PE.
It can be deduced that the selective use of prophylaxis
appears to be inadequate, as 57% of surgeons reported VTE
complications in their practice, with a 39% fatality rate. Only
37% of these patients had received VTE prophylaxis. This high
incidence of morbidity and mortality is significant and sug-
gests that prophylaxis either was not given or was not tailored
appropriately to the level of risk. It is important to adhere to
guidelines to ensure that moderate- and high-risk patients
receive optimum prophylaxis. The impression among senior
surgeons that the incidence of VTE is low among Asians is
probably based on their experience in practice. This percep-
tion must be treated with caution considering the low rates of
postmortem studies in this region and the clinically silent
nature of VTE among hospitalized patients. A recently pub-
lished study has indicated that the use of prophylaxis in-
creased from 29% to 57% in some centres following the imple-
mentation of educational strategies such as continuing medi-
cal education to increase awareness among clinicians.1 Such
policies should become the norm among health care institu-
tions to ensure up-to-date and high-quality care.
The perception among the medical fraternity that VTE is
not common in Asian patients should be dispelled to prevent
unnecessary morbidity and mortality. The current evidence
does not suggest that the incidence is low, as hospital admis-
sion and postmortem studies are retrospective and lack objec-
tive criteria in patient selection and diagnosis. Furthermore,
there appears to be a lack of adherence to guidelines or pro-
tocols, which would ensure optimum prophylaxis.
This survey suggests that selective use of prophylaxis among
surgeons appears to be inadequate as the morbidities reported
are significant. This is probably because the intensity of prophy-
laxis is not matched to the level of risk. Effective prophylaxis
depends on knowledge of specific clinical risk factors in indi-
vidual patients, which can be stratified into low, moderate,
high and very high.1 Recommendations on the type of prophy-
laxis should be based on the level of risk, and it is important for
the attending physician to be aware that multiple risk factors
may be present in some groups of patients. It can be argued
that routine prophylaxis can overcome problems associated
with selective utilization, which depends on individual prefer-
ence and assessing risk factors, the latter of which can be a
time-consuming and arduous task. This must, however, be
balanced against the economic burden and potential compli-
cations that are associated with anticoagulant use in surgical
patients. This policy is certainly not a viable option in this
region as the cost–benefit of such a strategy is unproven. The
most practical approach would be to match the intensity of
VTE prophylaxis to the level of risk based on standardized
national or hospital guidelines to ensure that patients receive
optimum prophylaxis with minimum associated morbidity.
Conclusion
The reluctance of surgeons to use prophylaxis stems from the
general lack of awareness of the current trends of DVT in the
Asian population and the perception that the incidence of this
preventable cause of death is too low to warrant routine
prophylaxis. Simple and effective pharmacological methods
of prophylaxis are available, but the fear of increased intra-
operative blood loss and wound haematomas seems to add
to the reluctance to use prophylaxis routinely. The increasing
incidence of VTE in the Asian population must be taken
seriously, and guidelines on VTE prophylaxis should be fol-
lowed so that a standardized approach can be used to ensure
that patients consistently receive adequate prophylaxis.
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